Product
IE
1 clinical trial
3 indications
Indication
Drug EffectIndication
MedicationIndication
ToxicityClinical trial
Apatinib in Combination With Ifosfamide and Etoposide (IE) for Relapsed or Refractory Osteosarcoma Progressed Upon First-line Chemotherapy (AIEO): a Prospective, Multiple-centre, Two-arm, Phase 2 TrialStatus: Completed, Estimated PCD: 2023-06-30